All Pharma News
Y-mAbs Appoints Peter Pfreundschuh As Chief Financial Officer

Y-mAbs Appoints Peter Pfreundschuh As Chief Financial Officer
GLOBENEWSWIRE
01 Jul 2024
Share Share
Y-mAbs: Preclinical GD2-SADA Data At SNMMI 2024

Y-mAbs: Preclinical GD2-SADA Data At SNMMI 2024
GLOBENEWSWIRE
06 Jun 2024
Share Share
Eupraxia Pharma: Phase 2 Knee Osteoarthritis Data At EULAR 2024

Eupraxia Pharma: Phase 2 Knee Osteoarthritis Data At EULAR 2024
GLOBENEWSWIRE
05 Jun 2024
Share Share
Y-mAbs` Naxitamab Shows New Phase 2 Interim Analysis At ASCO 2024

Y-mAbs` Naxitamab Shows New Phase 2 Interim Analysis At ASCO 2024
GLOBENEWSWIRE
01 Jun 2024
Share Share
Y-mAbs` GD2-SADA Preclinical Data Published At 2024 ASCO Annual Meeting

Y-mAbs` GD2-SADA Preclinical Data Published At 2024 ASCO Annual Meeting
GLOBENEWSWIRE
01 Jun 2024
Share Share
Y-mAbs Q1 2024 Results and Recent Developments

Y-mAbs Q1 2024 Results and Recent Developments
GLOBENEWSWIRE
07 May 2024
Share Share
Y-mAbs to Announce Q1 2024 Results on May 7

Y-mAbs to Announce Q1 2024 Results on May 7
GLOBENEWSWIRE
26 Apr 2024
Share Share
Y-mAbs Therapeutics Naxitamab-gqgk Receives Suppl Approval in the U.S

Y-mAbs Therapeutics Naxitamab-gqgk Receives Suppl Approval in the U.S
FDA
20 Mar 2024
Share Share
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer

Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
GLOBENEWSWIRE
14 Mar 2024
Share Share
Y-mAbs Appoints Executive Mary Tagliaferri, M.D. to its Board of Directors

Y-mAbs Appoints Executive Mary Tagliaferri, M.D. to its Board of Directors
GLOBENEWSWIRE
04 Mar 2024
Share Share